Portfolio Update

RNS Number : 6792W

Intl. Biotechnology Trust PLC

02 February 2012

 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC

Portfolio Update

The Board of International Biotechnology Trust plc (the "Company") notes the following changes in valuation to the unquoted portfolio during January 2012.

Aptiv Solutions, a £352k increase in value to £3.2m which reflects an improvement in the company's profitability and the rating of comparable companies in the Manager's EBITDA model.

Ricerca, a £95k increase in value to £972k which reflects an improvement in the company's revenue and the rating of comparable companies in the Manager's revenue valuation model.

Celerion, a £61k increase in value to £285k which reflects an improvement in the company's profitability and the rating of comparable companies in an EBITDA model.

Archemix, a £152k increase in value to £152k which reflects the valuation of escrow amounts from the deal signed with Baxter which are likely to be paid within six months.

Spinal Kinetics, a £77k write up in value to £398k which reflects the progress of the company in developing its products and growing revenues supported by the valuation of a recent acquisition in the same market space.

Reshape, a £(231)k reduction in value to £725k to reflect the progress of the business in its product development goals and the challenges of needing further funds this year.

Enquiries:

Kate Bingham/David Pinniger

Telephone: [phone]       

SV Life Sciences Managers LLP   

Investment Manager                                       

Rhona Gregg

Telephone: [phone]

BNP Paribas Secretarial Services Limited

Company Secretary

2 FEBRUARY 2012

 

END

 

 

PFUBGGDDBGGBGDD